Reform and Development of Rare Diseases Drug Evaluation and Approval in China
Rare diseases have a significant and profound impact on society, the economy, and the healthcare system. The path to developing drugs for rare diseases is particularly arduous. Due to the small number of patients and limited market demand, pharmaceutical companies don′t have enough incentives and re...
Saved in:
Main Authors: | HUANG Guo, YANG Zhimin, TANG Ling, ZHANG Jie, AI Xing, SE RI Geleng, ZHAO Tian |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Journal of Rare Diseases
2024-10-01
|
Series: | 罕见病研究 |
Subjects: | |
Online Access: | https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2024.04.005 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Approved antibacterial drugs in the last 10 years: from the bench to the clinic
by: Miguel García-Castro, et al.
Published: (2023-06-01) -
Drug repurposing screen for the rare disease ataxia-telangiectasia
by: Namrata Jayanth, et al.
Published: (2025-01-01) -
Assessment of potential drug-drug interactions in hospitalized patients with infectious diseases: an experience from a secondary care hospital [version 4; peer review: 2 approved, 2 not approved]
by: Padma G.M. Rao, et al.
Published: (2025-01-01) -
Real-Time Pharmacovigilance: Transforming Population-Based Monitoring of Post-Approval Vaccine Safety Through Rapid Cycle Analysis (RCA)—A Review of the Published Literature
by: Sampada Gandhi, et al.
Published: (2025-01-01) -
Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment
by: Cristina Camps-Fajol, et al.
Published: (2025-01-01)